@glycotope.com
We draw on long experience in glyco-biology to adress tumor specific glyco-epitope targets with potential for powerful anti-cancer activity.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
About
Description
Glycotope is a clinical stage biotechnology company with exceptional expertise in glycobiology and therapeutic antibody development. They utilize a proprietary technology platform to create uniquely tumor-specific monoclonal antibodies, focusing primarily on (immuno)-oncology. Their target-discovery approach allows them to identify proteins with abnormal glycosylation in cancerous tissues of various indications.
By targeting specific tumor-associated carbohydrate structures or protein/carbohydrate combined glyco-epitopes (GlycoTargets), their antibodies exhibit superior tumor-specificity. This enables them to be developed in different modes of action including naked antibodies, bispecifics, antibody-drug-conjugates, cellular therapies, or fusion-proteins. Headquartered in Berlin, Glycotope has a dedicated team of approximately 30 employees working on the further development of their technology and realizing their vision.
Their mission is to advance first-in-class antibody-based therapeutics for oncology, leveraging their world-leading glyco-biology expertise. To learn more or get in touch, visit their website
Company Type
Privately Held
Company Size
11-50
Year Founded
2000
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories